GRANT Guide

Home » Grants » Neuroimaging and CSF Biomarker Program (Alzheimer’s disease)

Neuroimaging and CSF Biomarker Program (Alzheimer’s disease)

The Neuroimaging and CSF Biomarker Program from the Alzheimer´s Drug Discovery Foundation provides funding to support the identification of biomarkers in Alzheimer´s disease. The grant is available to researchers worldwide, at both non-profit research institutions as well as for-profit organizations. Applicants may apply for up to 600,000 USD (direct costs only) for 1 year with the potential for renewal. There are three assessment rounds per year and the next letter of intent is due February 3, 2023 and the full application is due on April 7, 2023.

Sign in with your free account to see important eligibility criteria, including research location, citizenship, legal working rights and deadline/s.

Sign-up for the
scientifyRESEARCH
monthly research
funding newsletter

You can unsubscribe at any time.